Dr. Nathan J. Alves received his PhD in Chemical and Biomolecular Engineering from the University of Notre Dame. Following graduate school, he completed a post-doctoral research fellowship at the IU School of Medicine, where he began his work on the pharmaceutical delivery of clot-digesting enzymes utilizing a nanoparticle-based delivery system. He then spent two years at the Naval Research Labroatory (NRL) in DC on a National Academy of Science Research Associateship. Currently, Dr. Alves is the Director of Translational Research and an Assistant Professor at the Indiana University School of Medicine (IUSM) in the Department of Emergency Medicine with a joint appointment at Purdue University in Biomedical Engineering. The research he conducts, while spanning many disciplines, is centered on the development of translational technologies, treatments, and techniques that can be utilized to have a positive impact on people’s lives. He has extensive experience in: site-specific antibody modification, oriented antibody immobilization for advanced diagnostics, nanoparticle delivery, and packaging of pharmaceutical agents/enzymes to treat various diseases. His multidisciplinary background affords him a unique perspective to tackle complex therapeutic and medical device development problems.